Sabine D. Brookman-May Charbel Hobeika, MD Thanks Sabine for the shoutout! Important practice informing implications- to have a high threshold to use these agents unless absolutely needed.

🚀 Incredible poster presentation by Karl Semaan, MD, MSc on first-line systemic therapy following adjuvant immunotherapy in RCC at #ASCO24 🌟 Congrats!! ASCO ASCO TECAG OncoAlert

Fantastic presentation by Dr. Shilpa Gupta 👉pts reported outcomes from ph3 EV-302 trial ASCO #ASCO24 👉Rx with enfortumab+pembro significantly improved OS without adversely affecting QOL, pain or functioning. Tom Powles Bladder Cancer Advocacy Network OncoAlert Umang Swami, MD, MSCI, FASCO

Updates from the EV-302 study: Patient reported outcomes indicate meaningful improvements in pain score and overall quality of life favoring EV+P vs. chemotherapy. Great presentation by Shilpa Gupta ! ASCO Cleveland Clinic

Toni Choueiri, MD Dana-Farber Lank Center for Genitourinary Oncology showing that pembro+len superior sunitinib across all genotypes, signatures, molecular subtyoea, and PD-L1 status in ccRCC #ASCO24

CLEAR trial biomarkers for mRCC. Genomic signatures PBRM BAP1 all do NOT help therapy selection. Lenvatinib and Pembro just worked in all patients better than sunitinib. Complexities of biomarkers highlighted and need to externally validate always. #ASCO24 OncoAlert Toni Choueiri, MD

⭐️Toni Choueiri, MD presenting an exploratory biomarker analysis from the #CLEAR trial No predictive role of PDL1, gene mutations or RNA signatures, highlighting the ongoing unmet need to uncover #biomarkers of response to ICI in RCC. More work to be done! ASCO #ASCO24 OncoAlert

Brilliant discussion by our very own Dana-Farber Lank Center for Genitourinary Oncology Wenxin (Vincent) Xu ⭐️ ! Could #KIM1 be the awaited needle in the haystack of RCC biomarkers? Exciting results from multiple studies so far. Awaiting future prospective validation! ASCO #ASCO24 OncoAlert

Outstanding job by Shilpa Gupta presenting PRO data from EV-302. Really nice ti see such a deep drive into this important measures #ASCO24

Tremendous work by Conquer Cancer, the ASCO Foundation Merit Award Recipient ⭐️ Eddy Saad looking at the association between IL7 SNP and immune related adverse events in RCC #ASCO24 Dana-Farber Lank Center for Genitourinary Oncology Toni Choueiri, MD OncoAlert

22 yrs ago, purchased my 1st English medical textbook with English-Arabic dictionary as we studied medicine in Arabic 20 yrs ago, my 1st trip to US to improve my English Today Professor of Medicine! Many ups and downs in between, let alone visa issues What a Journey! V Thankful

Hi #MedTwitter! I’m Samer Salem, an #IMG from Lebanon researching Kidney Cancer at Brigham and Women's Hospital and applying for Internal Medicine residency. So excited to pursue my dream specialty! #Match2025 #InternalMedicine AAMC ID: 14538528

Hello #MedTwitter! I’m Eddy Saad, a USJ graduate 🇱🇧 and currently a postdoc fellow studying kidney cancer and immunotherapy 🤓 Dana-Farber Harvard Medical School Incredibly grateful for the opportunity to be applying for the #InternalMedicine #Match2025 ! AAMC ID: 16349429 #IMG

🔶 Visa related restrictions and challenges - Visa status impacts #IMGs throughout their careers, affecting match outcomes, job searches, research contributions, and overall well-being. - It’s essential for all of us to understand major visa categories and help #IMGs navigate

Very happy to match at UIC Heme Onc Fellowship for Hematology-Oncology fellowship! Excited to start this next chapter in beautiful Chicago! Couldn’t have done it without the support of my better half Gaëlle Rached, MD MSc and my amazing mentors. #fellowshipmatch #HemeOnc

#GU25 Proud of our MS3 Nikhil Pramod @CleClinicLCM for receiving the Conquer Cancer, the ASCO Foundation Merit award for his poster on deciphering immune-genomic markers of hyperPD with IO in pts with mUC! Jame Abraham, MD, FACP Timothy Chan Cleveland Clinic MD ASCO

Toni Choueiri, MD with the results of the ARC-20 trial evaluating the safety and efficacy of castadifan monotherapy in previously treated #ccRCC with promising data #GU24 Next: Phase 3 PEAK-1 trial of Cabozantinib +/- Casdatifan in PD-1 treated #RCC ASCO Dana-Farber

Great GU poster session #ASCO25 📍ctDNA in mUC (n=36) on EV: 92% were (+) Kevin Reyes Vadim Koshkin MD 📍real-world EV toxicities & d/c +survival @ronmamanti 📍KIM-1 in mRCC Mark Machaalani Toni Choueiri, MD Wenxin (Vincent) Xu 📍our University of Illinois Cancer Center team on HER3 overexpression in PCa

Thrilled to wrap up final days of residency with 1st place at Resident Research Day Fairview IMRP ! Immense gratitude to Shilpa Gupta for her exceptional mentorship. Eager to begin my Hematology-Oncology fellowship UIC Heme Onc Fellowship !

A warm welcome to our new heme/onc fellows 🌟 Charbel Hobeika 🌟 Philip Speigel 🌟 Jonny Trinh 🌟 Kate Proskuriakova 🌟 Rochelle Fayngor 🌟 Mustafa Wasifuddin & big thank you to VK Gadi for hosting!